MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$112.89
Tradestie Score
61
Market Cap
$225.13B
P/E Ratio
31.3
Revenue Growth
0.0%
Analyst Upside
+14.9%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABBV
ABBVIE INC.
|
$211.71
|
$431.71B | 99.4 | 63 | Compare |
|
PG
Procter & Gamble Company
|
$143.57
|
$358.52B | 20.8 | 56 | Compare |
|
NVO
Novo-Nordisk A/S
|
$46.21
|
$262.92B | 10.8 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$185.09
|
$261.56B | 27.9 | 48 | Compare |
|
NVS
Novartis AG
|
$149.93
|
$254.99B | 20.8 | 63 | Compare |
|
VZ
Verizon Communications
|
$47.16
|
$184.80B | 11.5 | 60 | Compare |
|
AMGN
Amgen Inc
|
$336.77
|
$160.70B | 22.9 | 58 | Compare |
|
PFE
Pfizer Inc.
|
$25.76
|
$154.70B | 19.7 | 59 | Compare |
|
GILD
Gilead Sciences Inc
|
$132.77
|
$137.92B | 18.2 | 59 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.59
|
$121.27B | 18.2 | 55 | Compare |
More MRK Analysis
Data updated: May 14, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry